Our Services
Medical Information
Helpful Resources
Published on: 9/26/2026
Ketorolac (brand name Toradol) is a strong nonsteroidal anti-inflammatory drug (NSAID) used for short-term relief of moderate to severe acute pain, such as pain after surgery or injury, kidney stone pain, and severe migraine, often when opioids are being avoided. Treatment is capped at 5 days total across all forms (injection, oral, nasal) because longer use sharply increases the risk of stomach ulcers and gastrointestinal bleeding, kidney injury, fluid retention, high blood pressure, and heart or clotting complications. Safe dosing also shifts with age, body weight, kidney function, pregnancy status, and other medications like blood thinners or additional NSAIDs, and there are several factors to consider before your next dose. See below to understand the full picture, including warning signs that mean you should stop the drug and seek care.
If pain is severe enough that you are relying on a medication like ketorolac, the underlying cause still matters, and a 5-day limit means you need a plan for what happens next. Take a free, instant, online symptom check to better understand what may be driving your pain and which next steps, tests, or type of clinician make the most sense for you.
Last reviewed for medical accuracy: 09/26/2026
Ketorolac is a prescription nonsteroidal anti-inflammatory drug (NSAID) commonly used for short-term management of moderate to severe pain. Its ability to reduce inflammation, fever, and pain makes it a valuable option in clinical settings. Understanding what is ketorolac used for and why its duration of use is strictly limited can help you make informed decisions about your pain management.
Ketorolac works by blocking enzymes (COX-1 and COX-2) involved in the production of prostaglandins, chemicals that promote inflammation, pain, and fever. It’s most often prescribed:
Postoperative pain
After surgeries (orthopedic, gynecologic, dental, etc.), ketorolac can reduce the need for opioids.
Acute musculoskeletal pain
Sprains, strains, back pain, or acute flare-ups of arthritis.
Renal colic (kidney stone pain)
Sometimes used in the emergency department to ease the intense pain of stones passing.
Migraine and headache relief
In select cases, under careful supervision, it can help when other NSAIDs aren’t effective.
Short-term management of gynecologic pain
Dysmenorrhea (painful periods) or pain after certain procedures.
Key point: Ketorolac is not intended for chronic pain control or long-term inflammation management (e.g., osteoarthritis). It is a bridge therapy to get you through intense pain episodes.
Ketorolac comes in several forms—injectable (intravenous or intramuscular), oral tablets, and an intranasal spray. Dosages vary by form:
Injectable (IV/IM):
First dose often 30 mg IV or 60 mg IM, followed by 15–30 mg every 6 hours as needed.
Oral tablets (10 mg):
10 mg every 4–6 hours, not exceeding 40 mg per day.
Intranasal spray (15.75 mg per nostril):
One spray in each nostril every 6–8 hours, up to four times per day.
Always follow your prescriber’s instructions. Do not increase your dose or frequency without medical guidance.
Unlike many NSAIDs, ketorolac carries a higher risk profile when used beyond 5 days. The maximum duration of combined parenteral and oral therapy should not exceed 5 days for adults. Reasons include:
Gastrointestinal (GI) risks
NSAIDs can irritate the stomach lining, leading to ulcers, bleeding, or perforation—risks that increase sharply after a few days.
Renal (kidney) impairment
Prostaglandins help maintain blood flow to the kidneys. Prolonged inhibition can cause acute kidney injury or worsen existing kidney disease.
Cardiovascular concerns
All NSAIDs may slightly raise blood pressure and increase the risk of heart attack or stroke, especially with long-term use.
Bleeding tendencies
Ketorolac impairs platelet function, which can exacerbate bleeding during surgery or in patients with clotting disorders.
Lack of tolerance data
Clinical trials and post-marketing data support safety and efficacy only for up to 5 days. Beyond that, the balance of benefit vs. risk becomes unfavorable.
All medications carry the possibility of side effects. With ketorolac, you may encounter:
Common (up to 1 in 10 people)
Less common (up to 1 in 100 people)
Rare but serious
If you notice signs of GI bleeding (black, tarry stools; vomiting blood), kidney problems (reduced urine output; swelling in legs), or allergic reactions, seek medical attention immediately.
Ketorolac is not appropriate for everyone. Contraindications include:
Always inform your healthcare provider about all medical conditions and medications (prescription, over-the-counter, herbal) to avoid interactions. NSAIDs can interact with blood thinners, certain antihypertensives, and other drugs.
If ketorolac is unsuitable or you need longer pain control, consider:
Each option has its own risk-benefit profile, so work with your provider to choose the safest, most effective therapy for your situation.
While on ketorolac, your doctor may recommend:
Be sure to report any unusual symptoms promptly. Early detection of side effects can prevent serious complications.
If you’re experiencing new or worsening pain, side effects, or other symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you determine whether you need urgent care, a routine appointment, or self-care measures.
Always seek immediate medical attention for:
Ketorolac can be an effective short-term pain reliever when used appropriately. However, serious side effects are possible if you exceed recommended durations or doses. Always:
Your health and safety are paramount. If you’re ever in doubt about what is ketorolac used for, how long you should take it, or whether you need a different approach, seek professional medical advice.
(References)
* Duarte C, Dunaway F, Turner L, Aldag J, Frederick R. Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial. Ann Emerg Med. 1992 Sep;21(9):1116-21. doi: 10.1016/s0196-0644(05)80654-7. PMID: 1514724.
* Miranda HF, Sierralta F, Pinardi G. Previous administration of indomethacin or naloxone did not influence ketorolac antinociception in mice. Anesth Analg. 1993 Oct;77(4):750-3. doi: 10.1213/00000539-199310000-00016. PMID: 8214659.
* Thagaard KS, Jensen HH, Raeder J. Analgesic and antiemetic effect of ketorolac vs. betamethasone or dexamethasone after ambulatory surgery. Acta Anaesthesiol Scand. 2007 Mar;51(3):271-7. doi: 10.1111/j.1399-6576.2006.01240.x. Epub 2007 Jan 25. PMID: 17257175.
* Sukmawan YP. Comparison and Impact of The Short-Term Use of Some Non-Aspirin NSAIDs on Bleeding Time of Mice. Cardiovasc Hematol Agents Med Chem. 2018;16(2):120-122. doi: 10.2174/1871525716666180913113040. PMID: 30210008.
* Hassan MK, Karlock LG. The effect of post-operative NSAID administration on bone healing after elective foot and ankle surgery. Foot Ankle Surg. 2020 Jun;26(4):457-463. doi: 10.1016/j.fas.2019.05.016. Epub 2019 May 31. PMID: 31196697.
* Shariatpanahi ZV, Shahbazi S, Shahbazi E. Ketorolac and Predicted Severe Acute Pancreatitis: A Randomized, Controlled Clinical Trial. Clin Med Res. 2022 Jun;20(2):74-80. doi: 10.3121/cmr.2021.1663. Epub 2022 Jan 7. PMID: 34996820; PMCID: PMC9242735.
* Ziesenitz VC, Welzel T, van Dyk M, Saur P, Gorenflo M, van den Anker JN. Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years. Paediatr Drugs. 2022 Nov;24(6):603-655. doi: 10.1007/s40272-022-00514-1. Epub 2022 Sep 2. PMID: 36053397; PMCID: PMC9592650.
* Ogilvie D, Ogilvie B, Mysore A, Joshi T, Drzala M, Kupershtein I, Reiter M, Hullinger H. Postoperative Ketorolac Administration and Pseudoarthrosis Following Lumbar Spinal Fusion: A Matched Cohort Study. Spine (Phila Pa 1976). 2026 Jan 1;51(2):85-91. doi: 10.1097/BRS.0000000000005474. Epub 2025 Aug 19. PMID: 40827608.
* Baumann AN, Trager RJ, Yazdanpanah S, Anastasio AT, Sanda T, Makowski M. Is postoperative ketorolac administration associated with nonunion in adults after proximal humerus open reduction and internal fixation? a propensity-matched retrospective cohort study. Injury. 2025 Nov;56(11):112693. doi: 10.1016/j.injury.2025.112693. Epub 2025 Aug 25. PMID: 40876112; PMCID: PMC13563193.
* Tamayo de Leon CD, Gama-Reyes EG, Paredes Moreno FA, Galnares-Olalde JA. Adjunctive occipital nerve block for emergency treatment of acute migraine: A randomized, controlled trial. Cephalalgia. 2025 Oct;45(10):3331024251381764. doi: 10.1177/03331024251381764. Epub 2025 Oct 16. PMID: 41100185.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.